Jim Cramer's Mad Money In-Depth Stock Picks, Feb. 22

Stocks discussed in the in-depth session of Jim Cramer’s Mad Money TV program, Thursday, February 22. Click on a stock ticker for more analysis:

Energy Metals (EMU), Cameco (CCJ)

Cramer says that the rest of the world is "leaving us in the dust" when it comes to nuclear power, and adds that there is room for uranium in any portfolio. Recently the price of uranium has increased to $75 a pound, and Cramer believes that the price will continue to rise. He discussed EMU as a good speculative play which is "not for the faint of heart" since it has no revenue yet, but it is still a relatively new company which may be bought by Cameco, since that company recently lost one of its largest facilities in a flood. Cramer urges investors to use limit orders when buying EMU and not to pay more than $12.

Related: James Finch predicts that fragmentation in the nuclear power industry will lead to consolidation.

Charter Communications (CHTR)

Cramer invited viewers to his bizarro world where an "ugly" debt-ridden stock can become beautiful because it can refinance its debt at lower yields. He compares CHTR to Level 3 Communications, which saw a rise after refinancing. Every time CHTR refinances, analysts can raise numbers, which will cause the stock to go higher, says Cramer, and he also likes CHTR because he believes it can catch up with the competition and obtain a triple-play of phone, internet and TV.

Wall of Shame: IBM 's (IBM) CEO Samuel Palmisano

IBM is one of those companies Cramer thinks will see a bounce if its CEO resigns, and he inducted Samuel Palmisano into his CEO Wall of Shame. Although the stock is at $100, it has gone from $103.02 to $98.50 since Palmisano has taken the helm, and Cramer thinks that the recent lift is temporary. In addition, Cramer noted that the company has decelerating growth and added "your bank account is outperforming this stock."

Related: Sramana Mitra discusses IBM's foray into social networking.

CEO Interview: Mark Miller Stericycle (SRCL)

Cramer asked Mark Miller if Stericycle's UK acquisition is a sign of saturation in the U.S., and Miller said that, on the contrary, the company is in a "fortunate position" of having the cash flow to make acquisitions that "supercharge the company's growth." Concerning government restrictions on medical waste, Mark Miller commented that the "regulatory framework always tends to help us" since the company outsources services from health care customers to conform with regulations. In addition, Miller added that transportation expenses are a "constant area for improvement" and that SRCL is making progress. Cramer commented that SRCL is a triple buy.

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightening Round, Stop Trading and his Market Minute.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with Jim Cramer, CNBC or TheStreet.com

Comments

[WilliamHuang]

They are good aricles. I like them.